Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 1,734 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Depressive Disorder, Major, Depressive Disorder, Minor, Dysthymic Disorder
Interventions: RESPECT-D, RESPECT-D-E (Enhanced); Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Keene, New Hampshire

Conditions: Alcohol Use, Drug Use
Interventions: Health Education Toolkit, Treatment-as-usual; Behavioral
Lead sponsor: Treatment Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus
Interventions: Finerenone (Kerendia, BAY948862), Others except finerenone; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 238,038 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Whippany, New Jersey

Conditions: Stroke, Cognitive Deficit, Cognitive Impairment, Short-Term Memory Impairment
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Healthy
Interventions: Interprofessional Simulation Experience; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Abdominal Subcutaneous Fat
Interventions: Ultrasound; Device
Lead sponsor: CAO Group, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Midvale, Utah

Conditions: Schizophrenia, Psychosis
Interventions: Active Trans-cranial direct-current stimulation, Sham Trans-cranial direct current stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 50 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Low Back Pain, Chronic Pain, Military Personnel, Veterans
Interventions: Physical Therapy, Move 2 Health (M2H), MORE Mindfulness; Behavioral
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 4
States / cities: Schofield Barracks, Hawaii • San Antonio, Texas • Tacoma, Washington

Conditions: Duchenne Muscular Dystrophy
Interventions: Transdiagnostic Behavioral Sleep Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 6 Years to 18 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Major Depressive Disorder
Interventions: Physical Activity-based Interventions; Behavioral
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Prematurity
Interventions: Electrical Inhibition (EI) Uterine Pacemaker; Device
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Cardiovascular Risk
Interventions: Behavioral Intervention; Behavioral
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Metastatic Prostatic Adenocarcinoma
Interventions: Opdivo Injectable Product, Yervoy Injectable Product, Cytoxan, Cryosurgical freezing (cryosurgery); Drug · Procedure
Lead sponsor: Rampart Health, L.L.C.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Lancaster, California • Rochester, Michigan

Conditions: Bronchopulmonary Dysplasia, Very Low Birth Weight Infant, Prematurity
Interventions: Enrollment; Other
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 1 Month to 7 Months
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Opioid-use Disorder
Interventions: Collaborative Care (CC), Extension for Community Healthcare Outcomes (ECHO); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 11
States / cities: Hartford, Connecticut • New Britain, Connecticut • New Haven, Connecticut + 7 more

Conditions: Lymphoma
Interventions: Enhanced Usual Care, SMART3RP-Lymphoma; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sickle Cell Disease
Interventions: NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 53
States / cities: Mobile, Alabama • Los Angeles, California • Oakland, California + 37 more

Conditions: Cocaine Dependence
Interventions: Galantamine, Computer Assisted Cognitive Behavioral Therapy (CBT); Drug · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 2
States / cities: Bridgeport, Connecticut • Stratford, Connecticut

Conditions: Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
Interventions: Dupilumab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 12 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 36
States / cities: Phoenix, Arizona • Apple Valley, California • La Jolla, California + 31 more

Conditions: Burn-Out Syndrome, Work-Related Stress Disorder
Interventions: Mindfulness-Based Cognitive Therapy, Book Club Active Control Intervention; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Intrahepatic Cholangiocarcinoma
Interventions: Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment, Consolidation Doublet Therapy:; Drug · Radiation
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Schizophrenia
Interventions: Individual Placement and Support, Workplace Fundamentals Module, Brokered Vocational Rehabilitation, Oral risperidone, Skills training group; Behavioral · Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2006
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Musculoskeletal Pain, Work Related Stress, Quality of Life, Grip
Interventions: Educational video on ergonomics, Verbal physical therapy coaching sessions; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: ADHD
Interventions: Methylphenidate Hydrochloride ER, Behavioral classroom, Placebo, General Classroom, Academic Accommodations; Drug · Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Miami, Florida • Amherst, New York

Search by objective public record fields.

Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial

Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits

High-Fidelity Patient Simulation on Clinical Reasoning Skills and Interprofessional Competencies

Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction

Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia

SMART Stepped Care Management for Low Back Pain in the Military Health System

Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy

Trial of Surf and Hike Therapy for Major Depressive Disorder

Pilot Study of Electronic Uterine Contraction Inhibitor

CREATION Health Lifestyle Intervention

A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma

Work of Breathing in Premature Infants at Discharge

Treatment of Pregnant Women With OUD

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have

A Mindfulness Based Cognitive Therapy (MBCT) Resiliency Program for Critical Care Nurses

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Improving Work Outcome in People With Recent-onset Schizophrenia

Physiatrist Ergonomic Intervention on Work Related Musculoskeletal Pain in Surgeons

Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom